NCT07532148 2026-04-15
Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Chong Kun Dang Pharmaceutical
Phase 1 Not yet recruiting
Clinical Trials
6 trialsNCT04500587 2024-09-19
Phase 1 First in Human Study of ZN-d5 as a Single Agent
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
Phase 1 Completed
NCT05758610 2024-05-08
A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients
Shengke Pharmaceuticals (Jiangsu) Limited, China
Phase 1 Recruiting
NCT04840784 2023-10-11
First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML
Shengke Pharmaceuticals (Jiangsu) Limited, China
Phase 1 Terminated
NCT04972422 2021-09-05
A Phase 1b Study of ZN-c3 in Chinese Subjects
Zentera Therapeutics HK Limited
Phase 1 Unknown
NCT03236974 2020-02-06
D6090C00002
AstraZeneca
Phase 1 Completed